Trials / Active Not Recruiting
Active Not RecruitingNCT00741728
Heart Rate, Baroreflex Sensitivity and Cardiovascular Morbidity and Mortality in the Population
Heart Rate, Baroreflex Sensitivity and Cardiovascular Morbidity and Mortality in the Population. The Paris Prospective Study III
- Status
- Active Not Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 10,157 (actual)
- Sponsor
- Institut National de la Santé Et de la Recherche Médicale, France · Other Government
- Sex
- All
- Age
- 50 Years – 75 Years
- Healthy volunteers
- Accepted
Summary
The aim of the present Paris Prospective Study III (PPS3) is (1) to assess the determinants of the regulation of heart rate and blood pressure variations and carotid properties (under different physiologic stimulations) and (2) to evaluate the respective contribution of heart rate, blood pressure variations and carotid properties to cardiovascular morbidity and mortality including sudden death during 10 years at least in healthy considered subjects.
Detailed description
Overall, 10 157 men and women have been recruited during May 2008 and June 2012 for an extensive clinical examination including a 2h holter electrocardiography (ECG), a carotid doppler echo tracking, a step test, as well as blood and DNA collections. Since then, the cardiovascular morbidity and mortality of the participants is being followed up for 10 years at least and will continue up to 2032.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Spider flash ECG, high-precision carotid echo-tracking, step test | cardiac rhythm recorded during health check up, vascular aging parameters and baroreflex sensitivity recorded during carotid echotracking of the right common carotid artery , step test during 2 minutes |
Timeline
- Start date
- 2008-05-13
- Primary completion
- 2032-06-01
- Completion
- 2032-12-01
- First posted
- 2008-08-26
- Last updated
- 2026-02-11
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT00741728. Inclusion in this directory is not an endorsement.